Provided by Tiger Trade Technology Pte. Ltd.

Cyclacel Pharmaceuticals

5.05
0.0000
Volume:- -
Turnover:- -
Market Cap:1.69M
PE:-125.44
High:5.05
Open:5.05
Low:5.05
Close:5.05
52wk High:17.00
52wk Low:3.29
Shares:335.30K
Float Shares:335.30K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0403
EPS(LYR):-33.4976
ROE:-1950.23%
ROA:-160.18%
PB:0.55
PE(LYR):-0.15

Loading ...

Dec 28, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 23, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 21, 2020

Major Issues Report

8-K - Current report
Dec 18, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

8-K - Current report
May 05, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 04, 2020

Major Issues Report

8-K - Current report
Apr 30, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 24, 2020

Major Issues Report

8-K - Current report
Apr 20, 2020

Major Issues Report

8-K - Current report
Apr 14, 2020

Major Issues Report

8-K - Current report
Apr 14, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 27, 2020

Major Issues Report

8-K - Current report
Mar 18, 2020

Major Issues Report

8-K - Current report
Mar 13, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Mar 05, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals